Synthesis of new pyrazoline-thiazoles and their biological activity

Authors

  • D. Ya. Havrylyuk Lviv National Medical University named after Danylo Halytsky, Ukraine

DOI:

https://doi.org/10.24959/ophcj.14.797

Keywords:

synthesis, thiazoles, pyrazolines, [2 3]-cyclization, biological activity

Abstract

The application of the [2+3]-cyclocondensation reaction for the synthesis of 2-pyrazoline substituted thiazolidinones, as well as bioisosteric pyrazoline-thiazoles has been analyzed. Following the literature data 4,5-dihydro- 1-carbothioamides are used as S,N-binucleophiles in the [2+3]-cyclocondensation reaction with different equivalents of the dielectrophilic synthon [C2]2+ (α-halogencarboxylic acids, derivatives of maleic acid, aroylacrylic acids, dimethyl ester of acetylenedicarboxylic acid, α-bromoacetophenones and ethyl 4-chloroacetoacetate). It has allowed to identify the highly active compounds with the antimicrobial, antiviral, anti-inflammatory, antitumor and antiparasitic activities. Aiming to enlarge a scope of 3,5-diaryl-4,5-dyhidropyrazol-1-carbothioamides as S,N-binucleophiles in [2+3]-cyclization and to find a new chemotherapeutic agents the synthesis of new pyrazoline-thiazoles has been carried out; it is based on the reaction between the carbothioamides mentioned and ethyl 2-chloroacetoacetate or 3-chloroacetyl acetone in the presence of fused sodium acetate in refluxing acetic acid. The structure of the compounds synthesized has been confirmed by 1H NMR spectra. The screening of the antitumor and antitrypanosomal activities of some compounds synthesized has been conducted. As a result of in vitro experiments their moderate cytotoxicity in the concentration of 10-5 mol/l for individual cancer cell lines has been identified. At the same time a high trypanocidal activity of compounds 2h and 2j has been determined against Trypanosoma brucei gambiense strain with the values of ІC50 of 3.82 and 2.61μM, respectively; and it exceeds the activity of the reference medicine nifurtomox.

Downloads

Download data is not yet available.

References

  1. Zimenkovsky B.S., Lesyk R.B. 4-Тhiazolidony. Chimiya, fiziologichna diya, perspektyvy (4-Thiazolidones. Chemistry, physiological action, perspectives). Vinnycya, Nova knyga, 2004, 106 p.
  2. Lesyk R., Zimenkovsky B. Curr. Org. Chem., 2004, Vol. 8, pp.1547-1577.
  3. Zimenkovsky B.S., Lesyk R.B. Klinichna farmaciya, farmakoterapiya ta medychna standartyzaciya – Clinical pharmacy, pharmacotherapy and medical standardization, 2010, No.3-4, pp.14-31.
  4. Lesyk R.B., Zimenkovsky B.S., Kaminskyy D.V. Kryshchyshyn A.P., Havrylyuk D.Ya., Atamanyuk D.V., Subtel’na I.Yu., Khyluk D.V. Biopolym Cell., 2011, Vol. 27, No.2, pp.107-117.
  5. Jain A.K., Vaidya A., Ravichandran V., Kashaw S.K., Agrawal R.K. Bioorg. Med. Chem., 2012, Vol. 20, pp.3378-3395.
  6. Kumar S., Bawa S., Drabu S., Kumar R., Gupta H. Recent Patents on Anti-Infective Drug Discovery, 2009, Vol. 4, pp.154-163.
  7. Shaaban M.R., Mayhoub A.S., Farag A.M. Expert Opin. Ther. Patents, 2012, Vol. 22, No.3, pp.253-291.
  8. Abdel-Wahab B.F., Abdel-Latif E., Mohamed H.A., Awad G.E.A. Eur. J. Med. Chem., 2012, Vol. 52, pp.263-268.
  9. El-Enany M.M., El-Meligie S.E.M., Abdou N.A., El-Nassan H.B. Oriental J. Chem., 2010, Vol. 26, No.4, pp.1265-1270.
  10. Desai N.C., Joshi V.V., Rajpara K.M. Med. Chem. Res., 2013, Vol. 22, No.8, pp.3663-3674.
  11. Desai N.C., Joshi V.V., Rajpara K.M., Vaghani H.V., Satodiya H.M. J. Fluorine Chem., 2012, Vol. 142, pp.67-78.
  12. Desai N.C., Rajpara K.M., Joshi V.V. Bioorg. Med. Chem. Lett., 2012, Vol. 22, pp.6871-6875.
  13. Yang Y.-S., Zhang F., Gao C., Zhang Y.-B., Wang X.-L., Tang J.-F., Sun J., Gong H.-B., Zhu H.-L. Bioorg. Med. Chem. Lett., 2012, Vol. 22, pp.4619-4624.
  14. El-Sabbagh O.I., Ibrahim S.M., Baraka M.M., Pannecouque C., Andrei G., Snoeck R., Balzarini J., Rashad A. A. Eur. J. Med. Chem., 2009, Vol. 44, pp.3746-3753.
  15. Havrylyuk D., Zimenkovsky B., Vasylenko O., Lesyk R. J. Heterocyclic Chem., 2013, Vol. 50, pp.E55-E62.
  16. Qiu K.-M., Yan R., Xing M. Bioorg. Med. Chem., 2012, Vol. 20, pp.6648-6654.
  17. Havrylyuk D., Zimenkovsky B., Vasylenko O., Gzella A., Lesyk R. J. Med. Chem., 2012, Vol. 55, pp.8630-8641.
  18. Havrylyuk D., Zimenkovsky B., Vasylenko O., Zaprutko L., Gzella A., Lesyk R. Eur. J. Med. Chem., 2009, Vol. 44, pp.1396-1404.
  19. Khalil N.A., Ahmed E.M., El-Nassan H.B. Med. Chem. Res., 2013, Vol. 22, No.2, pp.1021-1027.
  20. Rajendra P., Kumar G.V.S., Chandrashekar S.M. Med. Chem. Res., 2013, Vol. 22, No.5, pp.2061-2078.
  21. Seebacher W., Belaj F., Saf R., Brun R., Weis R. Monatsh. Chem., 2003, Vol. 134, No.12, pp.1623-1628.
  22. Danilkina N.A., Mikhaylov L.E., Ivin B.A. Chem. Het. Comp., 2011, Vol. 47, No.7, pp.886-900.
  23. Rudenko R.V., Komykhov S.A., Desenko S.M. Chem. Het. Comp., 2009, Vol. 45, No.8, pp.1017-1018.
  24. Havrylyuk D., Zimenkovsky B., Vasylenko O., Day C.W., Smee D.F., Grellier P., Lesyk R. Eur. J. Med. Chem., 2013, Vol. 66, pp.228-237.
  25. Boyd M.R., Paull K.D. Drug Development Research, 1995, Vol. 34, pp.91-109.
  26. Alley M.C., Scudiero D.A., Monks P.A. Cancer Research, 1988, Vol. 48, pp.589-601.
  27. Shoemaker R.H. Nature Reviews Cancer, 2006, Vol. 6, pp.813-823.
  28. Lethu S., Bosc D., Mouray E., Grellier P., Dubois J.J. Enzyme Inhib. Med. Chem., 2013, Vol. 1, pp.163-171.

Downloads

Published

2014-06-10

How to Cite

(1)
Havrylyuk, D. Y. Synthesis of New Pyrazoline-Thiazoles and Their Biological Activity. J. Org. Pharm. Chem. 2014, 12, 59-64.

Issue

Vol. 12 No. 2(46) (2014)

Section

Original Researches

License

Copyright (c) 2014 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:

1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.

2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.

3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).